Your SlideShare is downloading. ×
Using Sentiment Analysis in Pharma and Biotech
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Using Sentiment Analysis in Pharma and Biotech

2,773
views

Published on

This was my 5 minute Lightening Talk at the Sentiments Analysis Symposium in NYC, April 13th #sas10

This was my 5 minute Lightening Talk at the Sentiments Analysis Symposium in NYC, April 13th #sas10


0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
2,773
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
73
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Sentiment Analysis in Pharma Sally Church, Ph.D
  • 2. Understanding about how people feel about their treatment and disease is critical • PR tools give a big picture from media hits, but are less useful for more granular analysis. • Current buzz metric tools are useful for relative market share of noise, but not for deep analysis. • Traditional qualitative market research has limitations in human analysis. • Quantitative analysis for market segmentation is expensive and usually based on physician rather than patient sentiments. • Rise of science, patient bloggers and social media as an important mediums for evaluating sentiments means we need new and better tools.
  • 3. What is the basis of our approach? • The underlying philosophy of the Leximancer system is that meaning must be emergent from text and therefore not biased by external pre- definition. • This has resulted in a methodology involving identification of a Thesaurus of supporting defining terms being 'bootstrapped' to an original emergent seed-word, to form a Concept entity. • It is a fully-automated discovery process using the original text corpus.
  • 4. Analysis can be from private recorded interviews or public information on internet
  • 5. Control panels allow a deeper analytical framework to be applied by our analysts
  • 6. Using a Thesaurus of words, +ve or -ve associations can be established
  • 7. The tool groups together word associations to build a Concept Map
  • 8. You can also drill down to specifics to look at associations more carefully Unfavourable theme showing symptoms and side effects
  • 9. We are now working with Pharma clients using the tool in a number of different ways Market Research: • Qualitative interviews • Segmentation Sentiments can be: • Unmet medical needs • Therapies • Diseases PR and Advocacy: • Companies • Media Monitoring • Physicians or Patients • Issues Management • Social Media Outreach
  • 10. sally@icarusconsultants.com Icarus Consultants, Inc O: 201 204 9210 T: 201 780 2778

×